Recent advances in the field of immunology suggest that innate immune cells (e.g. dendritic cells, NK cells, phagocytes) are capable of displaying a form of ...
AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Lucy Gildea and her new cross-functional team will pioneer a new operating model to power up Mary Kay's global brand and ...
Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a biotechnology company focused on developing small molecule drugs for viral infections and liver diseases, is navigating a critical phase in its evolution.
A new Moffitt Cancer Center study has identified a specific immune response that may prevent the spread of breast cancer ...
L.A.’s bioscience research scene is likely to be completely transformed over the next few years as a major immunology ...
Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis and ...
A groundbreaking study has shown that children with high-threshold peanut allergies can build tolerance by consuming ...